|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-1-19
|
|
pubmed:abstractText |
To evaluate the tolerability, safety and efficacy of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease (PD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0300-9564
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
221-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15503197-Adult,
pubmed-meshheading:15503197-Aged,
pubmed-meshheading:15503197-Carbidopa,
pubmed-meshheading:15503197-Catechols,
pubmed-meshheading:15503197-Drug Combinations,
pubmed-meshheading:15503197-Drug Tolerance,
pubmed-meshheading:15503197-Female,
pubmed-meshheading:15503197-Humans,
pubmed-meshheading:15503197-Levodopa,
pubmed-meshheading:15503197-Male,
pubmed-meshheading:15503197-Middle Aged,
pubmed-meshheading:15503197-Nausea,
pubmed-meshheading:15503197-Parkinson Disease
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
An open-label evaluation of the tolerability and safety of Stalevo (carbidopa, levodopa and entacapone) in Parkinson's disease patients experiencing wearing-off.
|
|
pubmed:affiliation |
Mount Sinai Medical Center, New York, NY 10029, USA. william.koller@mssm.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
